Information For Authors
- Manuscript Submission Guidelines
- Author Benefits Program
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
Mary Ann Liebert, Inc. Submission Benefits Package
Your submission to Journal of Women's Health provides you with robust tools and support to ensure maximum impact and readership for your work. By submitting your manuscript, you’ll receive:
- Rapid, rigorous peer-review and editorial attention
- Immediate deposit to PubMed and other indexing services upon online publication
- Exposure to thousands of thought-leaders in your field, maximizing readers, citations, and downloads
- Fast Track online-ahead-of-print publication
- Global availability in over 170 countries
- Open Access publication options
Submitting Your Manuscript
Submitting your manuscript to Journal of Women's Health delivers a comprehensive benefits program that ensures high-quality review of your research and maximum impact for your work. Journal of Women's Health carries a manuscript processing charge* of $49.00 USD upon submission of each new manuscript.
Upon payment, you will be provided a Manuscript Submission Code, and will be prompted to enter this information when uploading your files to our peer-review system. Please note: Securing a token does not automatically create an account in our peer-review system. If you do not already have an account, you will be asked to create one before you can begin your submission.
Submissions do not need to be completed at once. Submitting authors/agents may begin the submission process, save their work, and return to the site to complete the upload(s) at a later time. There is no limit on the number of times one can save their work and subsequently resume the submission. Doing so will not incur additional charges.
All submitting authors are required to complete their submissions using an ORCID identifier. Please visit the ORCID website for more information, or to register.
Click here to submit your paper via our fast and user-friendly electronic submission system.
Processing charges and submission codes are NOT required for revisions to previously submitted papers. To upload a revision of a paper, the submitting author should log in to their Author Center at http://mc.manuscriptcentral.com/womenshealth and click on “Revised Manuscripts in Draft.” The paper will appear in this area, and the submitting author will be able to upload revised files without paying any charges or entering a submission code.
Please be sure to follow the Instructions for Authors below on Manuscript Preparation. Authors whose submissions do not comply with the Instructions for Authors will have their papers un-submitted so that the file(s) may be adjusted accordingly. Directions regarding the necessary corrective actions will be provided in an email to the corresponding author at the time the paper is un-submitted. The submitting author/agent will then be provided the opportunity to re-upload the corrected file(s). If a paper is un-submitted, the paper will reside in the corresponding author’s “Author Center” as a draft, and the submitting author/agent will be able to make the necessary adjustments and re-upload the paper without incurring another manuscript processing charge.
*The manuscript processing charge is independent of editorial decision and is non-refundable.
Instructions for Authors
Journal of Women's Health, a peer-reviewed journal, focuses on diseases and medical conditions that hold greater risk for and are more prevalent among women. It features clinically oriented papers, but review papers and case reports are also considered for publication. The emphasis of the Journal is on clinical research, especially in clinical trials, and on the basic science components relevant to those trials. The Journal does not publish papers that have been submitted elsewhere.
Be prepared to enter:
- The title of the article.
- You will be asked to enter the full names and institutional affiliations of all authors, the name (with complete address, phone and fax numbers, and e-mail address) to whom correspondence should be directed.
- A running title of no more than 45 characters (including spaces).
- Provide a structured Abstract of no more than 250 words, stating the background, methods, results (including the sample size), and conclusions drawn from the study.
- You will be asked to enter 3–5 keywords or phrases.
- Papers should contain original data concerning the course (prognosis), cause (etiology), diagnosis, treatment, prevention, or economic analysis of a clinical disorder or an intervention to improve the quality of healthcare.
You will also be asked for the names and e-mail addresses of at least five potential preferred reviewers familiar with the field. Please make sure preferred reviewers are not from your university or institution with whom you have collaborated. Anyone whom the author does not want to be considered should also be named as a non-preferred reviewer.
The author will also be asked to confirm that the material has not been published or submitted for publication elsewhere. All material published in the Journal will be copyrighted by Mary Ann Liebert, Inc.
All authors, including the co-authors, should be responsible for a significant part of the manuscript. All authors and co-authors should have taken part in writing the manuscript, reviewing it, and revising its intellectual and technical content. Any author whose name appears on a paper assumes responsibility and accountability for the results.
PREPARATION OF MANUSCRIPT
All manuscripts must be prepared in accordance with the "Uniform Requirements for Manuscripts Submitted for Biomedical Journals." Prepare text of manuscripts in Microsoft word double spaced. Leave ample margins on the sides, top, and bottom of pages. The order of items in the manuscript is: title page, abstract, text, acknowledgments, references, reprint address, legends, and tables. Each page, including the title page, must be numbered in the upper right-hand corner. Number pages consecutively.
Text. Maximum word count should not exceed 4000 words. In general, the text (which must be double spaced) should be organized under the headings: Introduction, Materials and Methods, Results, Discussion, and Conclusions. Use only standard abbreviations, which can be found in the AMA’s Manual for Authors & Editors or the Council of Biology Editors Style Manual. At first usage, spell out terms and give abbreviations in parentheses. Thereafter, use only abbreviations. It is not necessary to spell out standard units of measure, even at first usage. Use generic names for drugs if possible. If you wish to use a proprietary drug name the first time it appears, use the generic name followed by the proprietary name, manufacturer, and city in parentheses.
Acknowledgments. The author should acknowledge only those people and their institutions that have made significant contributions to the study.
Letters to the Editor
Journal of Women's Health will consider Letters to the Editor commenting on the scientific content of an article published in the Journal. Letters should not exceed 400-500 words of text and 5 references. Letters submitted for publication must be original and must not be submitted to any other publication simultaneously.
Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.” In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.htlm#conflicts for further guidance. If no conflicts exist, the authors must state “No competing financial interests exist."
When naming your figure files, please label them with the corresponding author’s last name, followed by a period (.), and then list the figure number. Ex: Jones.Fig1. Label figures and tables inside the files in addition to naming the file with the figure or table number. (ie: When figures or table files are opened, the figure or table number should appear inside the file.)
Please upload individual files of all manuscript material — do NOT upload a single PDF file containing all text, figure, and table files of your paper. Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.
If no conflicts exist, the authors must state “No competing financial interests exist."
References. References must be prepared double spaced and numbered consecutively as they are cited in the text (using superscript numbers). References appearing for the first time in tables and figures must be numbered in sequence with those cited in the text where the table or figure is mentioned. Use journal abbreviations as provided by MEDLINE, National Library of Medicine. List all authors when there are six or less. When there are more than six, list the first three, followed by et al. If references to personal communications or unpublished data are used, they are not to be in the list of references. They should be referred to in the text in parentheses: (F. P. Haseltine, personal communication). Include, among the references, papers accepted but not yet published; designate the journal, and add "In Press." The maximum number of references may not exceed 100.
Sample references are:
• Journal paper with up to six authors: 1. Karan LD, Hoegerman GS. Chemical dependency, HIV infection, and motherhood: A case presentation and discussion. Pediatr AIDS HIV Infect 1991;2:284-295.
• Journal paper with more than six authors: 2. Marana R, Luciano AA, Muzii L, et al. Reproductive outcome after ovarian surgery: Suturing versus nonsuturing of the ovarian cortex. J Gynecol Surg 1991;7:155-162.
• Book: 3. Pritchard JA, MacDonald PC, Gant NF. Williams obstetrics, 17th ed. Norwalk, CT: Appleton-Century-Crofts, 1985:457-469.
• Edited book: 4. Baggish MS, Barbot J, Valle RF, eds. Diagnostic and operative hysteroscopy. Chicago: Year Book Medical Publishers, 1989.
• Chapter in a book: 5. March CM. Hysteroscopy for infertility. In: Baggish MS, Barbot J, Valle RF, eds. Diagnostic and operative hysteroscopy. Chicago: Year Book Medical Publishers, 1989:136-145.
Reprint Address. Following the references, provide the name and complete address of the person to whom reprint requests should be sent.
Legends. You may enter the legends for each image as you upload each individual file, or you may upload a separate file for legends. Each legend for illustrations must be double spaced. In the legend, provide explanations for any abbreviations, arrows, etc. on the art work. If the illustration is taken from a copyrighted publication, credit must be given in the legend.
Tables. Prepare tables double spaced, each as a separate file, and provide a title for each table. Cite tables in sequence in the text. Explain abbreviations used in the body of the table in footnotes. If the table is taken from a copyrighted publication, credit must be given in a footnote. Maximum tables in a submission is 5. Tables must be saved in Microsoft word.
Figures. Cite figures consecutively in the manuscript within parentheses: Example: These keratotic areas can be confused with condyloma (Fig. 8A). A legend should be supplied for each illustration, and all legends numbered consecutively and provided (double spaced). Figures should be numbered in the order cited in the text. Images should not show the name of the manufacturer. Maximum figures in a submission is 5.
Electronic submission of art follows these caveats:
• Do not include any illustrations as part of your text file.
• Do not prepare any figures in Word as they are not workable.
• Line illustrations must be submitted at 1200 DPI.
• Halftones and color photos should be submitted at a minimum of 300 DPI.
• Adobe is the preferred software. Do NOT submit PowerPoint files.
• Save art as either TIFF or EPS files. Avoid submitting JPEG files.
• Color art must be saved as CYMK not RGB.
Materials taken from other sources must be accompanied by a written statement from both author and publisher giving permission to the Journal for reproduction. If clearance is required by the author’s institution, statements concerning such clearance should be provided in the manuscript. Obtain and submit written permission from authors to cite unpublished data or papers still in press.
Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
The Journal is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: (914) 740–2100; fax: (914) 740–2101; E-mail: firstname.lastname@example.org
Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option
Does your research funder have an open access mandate or would you like to expand the dissemination of your research?
The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.
The benefits of Liebert Open Access include:
- High visibility; open access articles are freely available online upon publication
- You retain copyright with the open access license allowing broad dissemination of your research
- You can freely share your article in repositories and research networks without restrictions
- Easy compliance with open access mandates
- Rigorous editorial and peer-review
- Targeted email announcement featuring a direct link to article
Identification and Marketing
Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.
Copyright and Licensing
If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
Ordering Open Access
Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email email@example.com.
Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form. You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.
Publishing biomedical or biotechnology research?
Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.
*Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.
Browse journals in the Liebert Open Access portfolio:
NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.
Publishing in Subscription Journals
By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.
Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.
The final published article (version of record) can never be archived in a repository, preprint server, or research network.
Publishing Open Access
Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email firstname.lastname@example.org or visit Liebert Open Access for more information.